Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-23

Clinical Trial Update: Effect of Dapagliflozin on IAH in T1DM [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effect of dapagliflozin on impaired awareness of hypoglycemia in adults with type 1 diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Diabetes Mellitus, Type 1, Hypoglycemia | Phase 2 | Status: COMPLETED